GlassScriptPhysician profile
Thompson T Kamba
NPI 1548279003
$4,362.07
in general payments reported to CMS, 2019-2025
24 companies · $457 in 2025
The $457 reported for 2025 was more than what 78% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $680 · 2021: $122 · 2022: $107 · 2023: $236 · 2024: $2,005 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,641 · Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,640.72 |
| Food and Beverage | $1,056.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,281.01 | 2023-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Bard Peripheral Vascular, INC. | $381.82 | 2020-2021 | |
| Penumbra, INC. | $361.18 | 2020-2022 | |
| Endocare, INC. | $301.38 | 2019 | |
| Imperative Care, INC | $126.25 | 2025 | Zoom 88-T Large Distal Platform |
| Pfizer INC. | $115.15 | 2019 | |
| Ethicon US, LLC | $110.89 | 2019 | |
| Teleflex LLC | $98.61 | 2025 | Barrigel |
| Hologic Sales and Service, LLC | $91.55 | 2024-2025 | 3dimensions, Brevera Breast Biopsy System |
| Argon Medical Devices, INC. | $78.66 | 2019 | |
| Healthtronics Stone Solutions, LLC | $70.49 | 2019 | |
| Varian Medical Systems, INC. | $61.79 | 2020 | |
| Seagen INC. | $56.38 | 2019-2023 | Adcetris |
| Janssen Biotech, INC. | $41.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $27.54 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.76 | 2025 | Keytruda, Welireg |
| Regeneron Healthcare Solutions, INC. | $19.93 | 2025 | Libtayo |
| Lilly USA, LLC | $19.89 | 2019 | |
| Puma Biotechnology, INC. | $19.12 | 2022 | |
| Tempus Ai, INC | $18.51 | 2024 | |
| Janssen Scientific Affairs, LLC | $16.27 | 2019 | |
| Tersera Therapeutics LLC | $14.69 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $13.41 | 2023 | Imbruvica |
| Eusa Pharma (US) LLC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thompson Kamba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.